UPC CFI 629/2026

The Brussels Local Division issued Order II under R.190 RoP, ordering Establishment Labs S.A. to produce evidence to the GC Aesthetics Defendants under Categories B, C, and D, timed to align with the parallel UK High Court disclosure order of 23 June 2026. The Court coordinated evidence production between UPC and UK proceedings in the interest of procedural efficiency and proportionality.

The Brussels Local Division granted the claimant ESTABLISHMENT LABS leave under R.263.3 RoP to limit its infringement claim by withdrawing the UK portion against Defendants 1, 2, 4 and 10. The Court held that Defendants 2 and 10 have no legal basis remaining in the infringement action but ordered them to remain parties for costs purposes, and granted leave to appeal.

The Brussels Local Division granted Defendants' R.190 RoP application for production of evidence (sales figures, physical samples, promotional materials, third-party test reports, technical specifications, performance qualification reports, regulatory documentation, and Design History File) relating to LABS's Motiva SilkSurface breast implants, while denying the request for post-priority-date physical samples (request I.c). Production is subject to a tiered compliance mechanism whereby if LABS provides pre-priority physical samples and declares prior public availability, the remaining documentary requests are waived; LABS is also ordered to pay a recurring penalty of EUR 2,000 per day of non-compliance.